These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8522132)

  • 1. [Autoimmune thrombocytopenic purpura after treatment of chronic viral hepatitis C with interferon].
    Maïga MY; Oberti F; Foussard C; Calès P
    Gastroenterol Clin Biol; 1995; 19(8-9):739-40. PubMed ID: 8522132
    [No Abstract]   [Full Text] [Related]  

  • 2. [Exacerbation of an autoimmune thrombocytopenic purpura during treatment with interferon alpha in a woman with chronic viral hepatitis C].
    Bacq Y; Sapey T; Gruel Y; Fimbel B; Degenne D; Barin F; Metman EH
    Gastroenterol Clin Biol; 1996; 20(3):303-6. PubMed ID: 8763070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: life-threatening severe immune thrombocytopenia after alpha-interferon therapy for chronic hepatitis C infection.
    Khan HA; Khawaja FI; Mahrous AR
    Am J Gastroenterol; 1996 Apr; 91(4):821-2. PubMed ID: 8677971
    [No Abstract]   [Full Text] [Related]  

  • 4. Idiopathic thrombocytopenic purpura during interferon-alpha 2B treatment for chronic hepatitis.
    Murakami CS; Zeller K; Bodenheimer HC; Lee WM
    Am J Gastroenterol; 1994 Dec; 89(12):2244-5. PubMed ID: 7977252
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of interferon-alpha 2B in the treatment of chronic viral hepatitis in patients with preexisting idiopathic thrombocytopenic purpura.
    Yoshida EM; Rock NR; Zeng L; Haniak WA; Anderson FH
    Am J Gastroenterol; 1995 May; 90(5):854-5. PubMed ID: 7605454
    [No Abstract]   [Full Text] [Related]  

  • 6. [Esophageal candidiasis during interferon therapy for chronic viral hepatitis C].
    Prignet JM; Galzin M; Demarquay JF; Raynard B; Louvety S; Künkel D
    Gastroenterol Clin Biol; 1994; 18(8-9):796-7. PubMed ID: 7875459
    [No Abstract]   [Full Text] [Related]  

  • 7. [Attempted suicide during treatment of chronic viral hepatitis C with interferon. Apropos of 2 cases].
    Bourat L; Larrey D; Michel H
    Gastroenterol Clin Biol; 1995 Dec; 19(12):1063. PubMed ID: 8729421
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of chronic hepatitis C with recombinant interferon alfa.
    Chen YK; Bala K
    West J Med; 1992 Jan; 156(1):72. PubMed ID: 1734608
    [No Abstract]   [Full Text] [Related]  

  • 9. [The treatment of hepatitis B and C with interferon-alpha can induce or aggravate psoriasis].
    Cervoni JP; Serfaty L; Picard O; Imbert JC; Poupon R
    Gastroenterol Clin Biol; 1995 Mar; 19(3):324-5. PubMed ID: 7781955
    [No Abstract]   [Full Text] [Related]  

  • 10. Antithyroid peroxidase antibody and development of silent thyroiditis during interferon-alpha 2a treatment of chronic hepatitis C.
    Wada M; Shimoyama T; Hamada A; Fukuchi M
    Am J Gastroenterol; 1995 Aug; 90(8):1366-7. PubMed ID: 7639264
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune thrombocytopenia and alpha-interferon therapy.
    Dourakis SP; Deutsch M; Hadziyannis SJ
    J Hepatol; 1996 Dec; 25(6):972-5. PubMed ID: 9007728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mucocutaneous lichen planus induced by a second treatment with high-dose interferon-alpha in a patient with chronic viral hepatitis C].
    Perreard M; Constant T; Monges D; Djaghri N; Angeli-Besson C; Gerolami A
    Gastroenterol Clin Biol; 1994; 18(11):1051. PubMed ID: 7705576
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe autoimmune thrombocytopenic purpura during interferon-alpha therapy for chronic myelogenous leukemia.
    Arimura K; Arima N; Ohtsubo H; Matsushita K; Kukita T; Ayukawa T; Kuroki T; Tei C
    Acta Haematol; 2004; 112(4):217-8. PubMed ID: 15564735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of chronic hepatitis B, C and D with alpha-interferon].
    Niederau C
    Fortschr Med; 1993 Feb; 111(6):35-7. PubMed ID: 8462911
    [No Abstract]   [Full Text] [Related]  

  • 15. [Epidemiologic studies and treatment of chronic viral hepatitis C].
    Ouzan D
    Med Trop (Mars); 1994; 54(3 Suppl):18-20. PubMed ID: 7596256
    [No Abstract]   [Full Text] [Related]  

  • 16. [Interferon therapy in chronic viral hepatitis].
    Welland O
    Nord Med; 1992; 107(3):72-3, 75. PubMed ID: 1549455
    [No Abstract]   [Full Text] [Related]  

  • 17. Interferon therapy in hepatitis C--refractory hepatitis--report of the research subgroup of treatment of chronic hepatitis.
    Iino S
    Gastroenterol Jpn; 1993 Mar; 28 Suppl 4():139-42. PubMed ID: 8486225
    [No Abstract]   [Full Text] [Related]  

  • 18. Lack of sustained efficacy of interferon in patients with chronic hepatitis C.
    Vento S; Concia E; Ferraro T
    N Engl J Med; 1996 May; 334(22):1479-80. PubMed ID: 8618600
    [No Abstract]   [Full Text] [Related]  

  • 19. Why we should treat chronic viral hepatitis.
    King PD
    Postgrad Med; 1996 Sep; 100(3):68-70, 73; discussion 73, 78. PubMed ID: 8795647
    [No Abstract]   [Full Text] [Related]  

  • 20. Interferon alpha 2a in patients of chronic hepatitis C.
    Zuberi SJ; Alam SE; Raza S
    J Pak Med Assoc; 1994 Jul; 44(7):171-2. PubMed ID: 7933458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.